SCHEMBL4390773

SCHEMBL4390773

Nc1ccc(-c2cc(C(=O)NCC3CCC(CNC(=O)O)CC3)c3ccccc3n2)cc1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACACB O00763 8/20 0.65
ACACA Q13085 6/20 0.63
KDM4E B2RXH2 7/20 0.58
ALDH1A1 P00352 7/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C9 P11712 1/20 0.56
TACR3 P29371 1/20 0.56
GAA P10253 3/20 0.55
LMNA P02545 2/20 0.52
HPGD P15428 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
VCP P55072 1/20 0.51
NPC1 O15118 1/20 0.51
TP53 P04637 1/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51
POLB P06746 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4390770 1.00 ACACB (0.65) ACACBACACAKDM4EALDH1A1L3MBTL1
SCHEMBL4391974 0.92 ACACB (0.74) ACACBACACAKDM4EALDH1A1L3MBTL1
SCHEMBL4391971 0.92 ACACB (0.74) ACACBACACAKDM4EALDH1A1L3MBTL1
SCHEMBL4394732 0.91 ACACB (0.66) ACACBACACAKDM4EALDH1A1L3MBTL1
SCHEMBL4390184 0.91 ACACB (0.69) ACACBACACAKDM4EALDH1A1L3MBTL1
SCHEMBL4394736 0.91 ACACB (0.66) ACACBACACAKDM4EALDH1A1L3MBTL1
SCHEMBL4009702 0.91 ACACB (0.69) ACACBACACAKDM4EALDH1A1L3MBTL1
SCHEMBL4400926 0.90 ACACB (0.67) ACACBACACAKDM4EALDH1A1L3MBTL1
SCHEMBL4400923 0.90 ACACB (0.67) ACACBACACAKDM4EALDH1A1L3MBTL1
SCHEMBL4009109 0.90 ACACB (0.66) ACACBACACAKDM4EALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090306133-A1 New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087 ASTRAZENECA AB (SE) 2009-12-10 US claimed
US-20090306133-A1 New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087 ASTRAZENECA AB (SE) 2009-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306133-A1 New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087 ACACA, ACACB, ACAT1 ACACB 2/4885ACACA 1/4885KDM4E 1761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.